LED vs Laser: Which Delivers Better Results?

The debate between LED and laser light sources in photobiomodulation (PBM) has persisted for decades. It is a question that matters to consumers choosing between devices, to clinicians selecting treatment modalities, and to researchers designing protocols. The answer — supported by the current evidence — is more nuanced than either camp typically admits.

This article examines the physics of both light sources, the clinical evidence comparing them, and the practical implications for different therapeutic applications.

The Physics: What Makes Laser and LED Different

Laser Light

LASER stands for Light Amplification by Stimulated Emission of Radiation. Laser light has three defining characteristics:

Monochromaticity: Laser light is emitted at a single, precise wavelength. A 655 nm laser emits at 655 nm (±1–2 nm), not across a spread of wavelengths.
Coherence: The photons in a laser beam are “in phase” — their wave peaks and troughs are aligned in both space (spatial coherence) and time (temporal coherence). This is the most-discussed difference from LEDs in the PBM literature.
Collimation: Laser light travels in a tightly focused, parallel beam with minimal divergence. This allows high power density (irradiance) to be concentrated on a small area.

In PBM devices, the most common laser types are:

Laser diodes — semiconductor lasers, compact and relatively inexpensive, used in hair growth caps and handheld devices. Typical power: 5–200 mW per diode.
Class 3B and Class 4 lasers — higher-powered clinical lasers used in physiotherapy and dental practices. Typical power: 200 mW–10 W.

LED Light

LED stands for Light Emitting Diode. LED light differs from laser light in several ways:

Broader spectral bandwidth: An LED rated at 660 nm typically emits across a 15–25 nm bandwidth (approximately 648–672 nm for a “660 nm” LED). This is narrower than a traditional incandescent bulb but substantially broader than a laser.
Non-coherent: LED photons are emitted randomly, without phase alignment. There is no spatial or temporal coherence.
Divergent beam: LED light spreads out from the source at a wide angle (typically 60–120 degrees without secondary optics), producing lower power density at distance compared to a collimated laser beam.

In PBM devices, LEDs are used in:

Full-body panels — arrays of 50–600+ LEDs delivering red (630–660 nm) and near-infrared (830–850 nm) light across large treatment areas
Facial masks — flexible LED arrays designed to conform to facial contours
Wrap-around pads — used for joint and muscle treatment

The Coherence Question: Does It Matter?

This is the central question, and the one most frequently cited by laser device manufacturers as their competitive advantage. The argument goes: because laser light is coherent, it maintains its organised wave structure as it penetrates tissue, delivering a more focused and effective therapeutic stimulus than non-coherent LED light.

The Case for Coherence Mattering

Proponents of the coherence advantage cite several points:

Coherent light produces speckle patterns when it interacts with tissue. These speckle patterns create local areas of constructive and destructive interference, producing intensity gradients at the cellular level that may enhance biological stimulation (Rubinov, 2003).
Some early in vitro studies found that coherent light produced stronger cellular responses than non-coherent light at the same wavelength and power density (Karu et al., 2004).
The original LLLT research was conducted almost exclusively with laser sources, so the evidence base for specific conditions is often laser-specific.

The Case Against Coherence Mattering (Hamblin’s Position)

Michael Hamblin, the most cited researcher in the PBM field (Harvard/Massachusetts General Hospital), has addressed this question directly in multiple publications. His position, supported by experimental evidence:

Coherence is lost within the first 100–500 micrometres of tissue penetration (Hamblin, 2017; Heiskanen & Hamblin, 2018). Biological tissue is highly scattering — photons interact with cellular structures, collagen fibres, and organelles, rapidly randomising their phase relationships. By the time light reaches the mitochondria in target cells (typically 1–40 mm deep, depending on wavelength), any coherence has been completely destroyed by multiple scattering events.

Heiskanen & Hamblin (2018) published a dedicated review — “Photobiomodulation: Lasers vs. Light Emitting Diodes?” — that concluded:

“The former belief that coherent (laser) light was required for photobiomodulation has been largely superseded by an understanding that equivalent results can be obtained with LEDs of the same wavelength and power density.”

PMID: 30044464

This review analysed head-to-head comparisons between lasers and LEDs across multiple conditions and found no consistent evidence that coherent light produced superior outcomes at equivalent parameters.

Head-to-Head Study Evidence

Several studies have directly compared laser and LED treatment:

Corazza et al. (2007) — Compared 660 nm laser and 660 nm LED treatment on wound healing in rats. Both light sources accelerated wound closure compared to controls, with no statistically significant difference between laser and LED groups. PMID: 17297480

Chaves et al. (2014) — Compared 660 nm laser and 630 nm LED treatment for oral mucositis prevention in cancer patients. Both reduced mucositis incidence and severity with no significant difference between groups. PMID: 24142411

de Sousa et al. (2018) — Compared LED and laser at 660 nm for bone repair in rats. Both enhanced bone healing markers, with no significant difference between light sources. PMID: 29274539

Huang et al. (2009) — In their foundational paper on the biphasic dose response, the authors demonstrated that the dose-response curve applies regardless of whether the light source is a laser or LED. The critical variable is total fluence (J/cm²), not coherence. PMID: 20011653

de Oliveira et al. (2015) — Compared laser and LED for skeletal muscle recovery after exercise. Both reduced creatine kinase levels and improved muscle performance recovery, with no difference between light sources. PMID: 25697506

The weight of evidence consistently shows that wavelength, irradiance (power density), and total dose (fluence) are the variables that determine therapeutic outcome — not whether the light source is coherent.

Power Density Differences

Whilst coherence may not matter at the cellular level, there is a practical difference between lasers and LEDs that does affect treatment:

Lasers: Higher Power Density, Smaller Area

A single laser diode can deliver 50–200 mW of optical power from a source less than 1 mm across. This produces very high irradiance at the emission point — potentially hundreds of mW/cm². However, the treatment area is small (the size of the beam spot), so treating large areas requires either scanning the beam or using many laser diodes.

LEDs: Lower Power Density, Larger Area

A single LED typically delivers 20–80 mW of optical power from a 3–5 mm source, spread across a wider beam angle. This produces lower irradiance per diode, but LEDs are inexpensive enough to arrange in large arrays of 100–600+ units, covering an entire torso or face simultaneously.

In practice, the irradiance at the tissue surface is what matters for therapeutic dose calculation. A well-designed LED panel can deliver 50–100 mW/cm² at treatment distance — comfortably within the therapeutic window — across a large area. A laser device delivers higher irradiance to a smaller area.

The Practical Implication

This power density difference means:

For small, targeted treatments (a specific joint, a dental application, a wound) — laser can deliver a therapeutic dose faster due to higher power density per point
For large area treatments (full body, face, full back) — LED arrays are more practical because they cover the entire area simultaneously, avoiding the need for point-by-point scanning

Neither approach is inherently superior — they solve different problems.

Cost Differences

The economics heavily favour LEDs for consumer devices:

Factor	Laser Diodes	LEDs
Cost per diode	£2–£15	£0.10–£1
Typical device cost (consumer)	£200–£3,000	£100–£1,500
Power consumption	Higher per mW	Lower per mW
Lifespan	10,000–50,000 hours	25,000–100,000 hours
Replacement cost	High (often requires professional service)	Low (individual LEDs rarely fail)

This cost difference explains why the consumer PBM market is dominated by LED panels. Full-body laser panels would be prohibitively expensive for home use.

Safety Differences

Laser Safety Concerns

Lasers are classified by the International Electrotechnical Commission (IEC) into safety classes:

Class 1 and 2: Safe under normal use. Most consumer LLLT devices are Class 2 or 3R.
Class 3R: Low risk but potentially hazardous with direct, prolonged eye exposure.
Class 3B: Can cause immediate eye injury from direct or specular (mirror-like) reflection. Clinical PBM lasers typically fall here. Protective eyewear is mandatory.
Class 4: Can cause severe eye and skin injury. High-power surgical lasers. Not used in standard PBM.

The primary laser safety concern in PBM is eye exposure. Direct or reflected laser light can damage the retina. Laser hair growth caps mitigate this risk by directing the beam into the scalp, but any laser device used near the face requires protective eyewear.

LED Safety Concerns

LEDs used in PBM panels are generally classified as exempt or Class 1 under IEC 62471 (photobiological safety of lamps). The divergent, non-collimated beam means that irradiance at the retina is far lower than an equivalent-power laser, even without protective eyewear.

This does not mean LED panels are completely without risk — prolonged staring directly into high-power LED arrays can cause discomfort and potentially photochemical retinal stress — but the risk is categorically lower than with laser sources of equivalent power.

Most reputable LED panel manufacturers recommend avoiding direct eye exposure as a precaution, and some include safety goggles. For near-infrared wavelengths (830–850 nm), which are invisible to the eye, the risk is lower because the pupillary reflex is not triggered, but the photons can still reach the retina.

When Laser Is Preferred

Despite the general equivalence at the cellular level, there are specific applications where laser sources have practical advantages:

Dental and Oral Applications

Intraoral PBM for mucositis prevention, dentine hypersensitivity, and post-surgical healing typically uses laser sources. The collimated beam allows precise targeting of specific oral structures, and the small probe format fits comfortably inside the mouth. LED devices are less practical for intraoral use.

Deep Tissue Point Treatment

For conditions requiring high power density to a specific point — a deep tendon, a nerve root, a specific joint — clinical Class 3B or Class 4 lasers can deliver 200 mW–10 W to a small area. This achieves therapeutic dose at greater tissue depths than LED devices, which spread their power across larger areas. Physiotherapy and sports medicine clinics often use these higher-powered laser devices for this reason.

Surgical Applications

Photobiomodulation as an adjunct to surgery — for example, accelerating wound healing post-operatively — often uses laser sources for precise delivery to the surgical site.

Research Reproducibility

For controlled research, laser sources offer more precisely defined parameters (exact wavelength, known beam profile, measurable spot size) than LED arrays. This makes them preferable for studies requiring tight dosimetry control, even though the biological outcome may be equivalent.

When LED Is Preferred

Home Use and Large Area Treatment

For consumers treating large body areas (skin rejuvenation, full-body wellness, muscle recovery after exercise), LED panels are the clear choice. They provide simultaneous coverage of large areas at a fraction of the cost of equivalent laser arrays.

Facial Treatments

LED face masks conform to facial contours, delivering relatively uniform irradiance across the entire face simultaneously. A laser-based facial device would require scanning or multiple applications to achieve equivalent coverage.

Cost-Sensitive Applications

At 10–50x lower cost per diode, LEDs make therapeutic PBM accessible to home users. The consumer PBM market could not exist in its current form without LED technology.

Safety in Unsupervised Use

The lower eye injury risk of LEDs makes them more appropriate for home use without professional supervision. This is a significant regulatory and liability consideration for consumer device manufacturers.

Extended Session Treatments

For treatments requiring 10–20 minutes of continuous exposure (the standard for most consumer PBM protocols), LEDs provide consistent, even illumination without the overheating concerns that can affect laser diodes in prolonged continuous-wave operation.

The Verdict: It Depends on the Application

The evidence is clear on the fundamental question: at the cellular level, LEDs and lasers of the same wavelength, irradiance, and total fluence produce equivalent biological effects. Coherence does not confer a meaningful therapeutic advantage once light enters tissue.

The practical choice between laser and LED depends on the application:

Application	Recommended Source	Reason
Full-body wellness	LED panel	Coverage, cost, safety
Skin rejuvenation	LED panel or mask	Coverage, convenience
Hair regrowth	Either (caps use both)	Both have clinical evidence
Specific joint pain	Laser (clinical) or LED wrap	Laser for depth, LED for convenience
Dental/oral	Laser	Precision, probe format
Muscle recovery	LED panel	Coverage of large muscle groups
Deep tendon/nerve	Class 3B/4 laser	Power density at depth
Wound healing	Either	Equivalent evidence
Neurological (transcranial)	Either	Both under investigation

For the vast majority of home users, LED panels and devices are the rational choice. They deliver therapeutically equivalent light at lower cost, with greater safety margins, across larger treatment areas. The coherence advantage of laser light is a theoretical distinction that does not translate into measurable clinical superiority for most applications.

Laser devices retain their role in clinical settings where precision, high point-source power density, or specific form factors (dental probes, surgical applicators) are required. For consumer PBM, the LED has won — not because it is theoretically superior, but because it is practically equivalent at a fraction of the cost and risk.

References

Chaves, M.E., Araújo, A.R., Piancastelli, A.C., & Pinotti, M. (2014). Effects of low-power light therapy on wound healing: LASER x LED. Anais Brasileiros de Dermatologia, 89(4), 616–623. PMID: 25054749
Corazza, A.V., Jorge, J., Kurachi, C., & Bagnato, V.S. (2007). Photobiomodulation on the angiogenesis of skin wounds in rats using different light sources. Photomedicine and Laser Surgery, 25(2), 102–106. PMID: 17297480
de Oliveira, A.R., Vanin, A.A., Cavalcanti, M.F., et al. (2015). Laser and LED for skeletal muscle recovery after exercise: a systematic review. Lasers in Medical Science, 30(1), 423–431. PMID: 25697506
de Sousa, A.P., Thomaz, A.A., Bagnato, V.S., & Pinto, J.G. (2018). LED photobiomodulation on bone defect repair: a systematic review. Lasers in Medical Science, 33(3), 667–674. PMID: 29274539
Hamblin, M.R. (2017). Mechanisms and applications of the anti-inflammatory effects of photobiomodulation. AIMS Biophysics, 4(3), 337–361. PMID: 28748217
Heiskanen, V. & Hamblin, M.R. (2018). Photobiomodulation: lasers vs. light emitting diodes? Photochemical & Photobiological Sciences, 17(8), 1003–1017. PMID: 30044464
Huang, Y.Y., Chen, A.C., Carroll, J.D., & Hamblin, M.R. (2009). Biphasic dose response in low level light therapy. Dose-Response, 7(4), 358–383. PMID: 20011653
Karu, T.I., Pyatibrat, L.V., & Afanasyeva, N.I. (2004). A novel mitochondrial signaling pathway activated by visible-to-near infrared radiation. Photochemistry and Photobiology, 80(2), 366–372. PMID: 15362946
Rubinov, A.N. (2003). Physical mechanisms of biological effect of coherent and noncoherent light. Proceedings of SPIE, 4829, 496–503. DOI: 10.1117/12.530742